SCHEDULE 13G Filed 2026-08-24 Event — SEC 0001104659-26-100403 →

INTEGRATED CORE STRATEGIES (US) LLC → Tenaya Therapeutics, Inc. TNYA

Stake: — Shares: — Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

10 transactions

3 buys · 7 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-08-14

DTC 10.00

21,100,721 shares short · -4.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $27K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-17	Ali Faraz	director, officer	Sale	5,837	$0.71	$4K
2026-08-17	Ali Faraz	director, officer	Sale	3,969	$0.71	$3K
2026-08-17	Ali Faraz	director, officer	Sale	5,020	$0.71	$4K
2026-08-17	Ali Faraz	director, officer	Sale	7,406	$0.71	$5K
2026-08-17	Tingley Whittemore	officer	Sale	1,637	$0.71	$1K
2026-08-17	Tingley Whittemore	officer	Sale	1,871	$0.71	$1K
2026-08-17	Tingley Whittemore	officer	Sale	2,279	$0.71	$2K
2026-05-28	Williams R Sanders	director	Award	120,000	$0.80	$96K
2026-05-28	Walsh Jeffrey T.	director	Award	120,000	$0.80	$96K
2026-05-28	Stehman-Breen Catherine	director	Award	120,000	$0.80	$96K

Other 13D/G Filings on Tenaya Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-05-14	SCHEDULE	COLUMN GROUP III, LP	30.30%	49,313,559	view →
2025-03-07	SCHEDULE	COLUMN GROUP III, LP	32.00%	49,313,559	view →
2025-03-07	SCHEDULE	Casdin Capital, LLC	4.30%	6,732,971	view →
2023-02-21	SC	COLUMN GROUP III, LP	—	—	view →
2022-11-28	SC	Casdin Capital, LLC	—	—	view →

Other Filings by INTEGRATED CORE STRATEGIES (US) LLC

Filed	Form	Issuer	Stake	Shares
2026-08-24	SCHEDULE 13G	Collegium Pharmaceutical, Inc.	—	—	view →
2026-06-18	SCHEDULE 13G	Edesa Biotech, Inc. EDSA	—	—	view →
2026-06-17	SCHEDULE 13G	TPG Inc. TPGXL	—	—	view →
2026-06-11	SCHEDULE 13G	Once Upon a Farm, PBC OFRM	—	—	view →
2026-06-10	SCHEDULE 13G	Quince Therapeutics, Inc. QNCX	—	—	view →
2026-05-26	SCHEDULE 13G	Amanat Acquisition Corp AMAN	—	—	view →
2018-01-08	SC	TETRAPHASE PHARMACEUTICALS INC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →